Know Cancer

or
forgot password
  • cancer clinical trials in bronx, NY

  • Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
    Montefiore Medical Center
    Bronx, New York 10467-2490
    MDS, AML, Solid Tumors, Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Kidney Cancer
    ChemoFx® PRO - A Post-Market Data Collection Study
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell
    Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Brain Tumor, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma
    Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Lung Cancer, Non Small Cell Lung Cancer
    Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
    Montefiore Medical Center MMC
    Bronx, New York 10467
    Symptomatic Refractory Resistant Carcinoid Disease
    Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Hepatocellular
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Non-small Cell Lung Cancer
    Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Non Small Cell Lung Cancer
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Bronx River Medical Associates, P.C.
    Bronx, New York 10467
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors
    Montefiore-Einstein Cancer Center
    Bronx, New York 10461
    Cancer
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Bronx, New York 10461
    Diabetes Mellitus
    Prolonged Grief in Young Bereaved Spouses and Partners
    Calavery Hospital
    Bronx, New York 10462
    Grief
    Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Advanced Solid Tumors
    Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
    Montefiore Medical Center Weiler Division
    Bronx, New York 10461
    Acute Myeloid Leukemia, AML
    A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Advanced Carcinoma, Non-small Cell Lung Cancer
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    Bronx, New York 10461
    Solid Tumors
    Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
    Local Institution
    Bronx, New York
    Melanoma
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Acute Myeloid Leukemia
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Albert Einstein College of Medicine

    Trial Locations
    Albert Einstein College of Medicine
    Montefiore Medical Center
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
    Albert Einstein Cancer Center
    Bronx, New York 10461
    Advanced Solid Tumors
    Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
    Montefiore Medical Center, Department of Nuclear Medicine
    Bronx, New York 10461
    Non Small Cell Lung Cancer
    Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
    Local Institution
    Bronx, New York
    Chronic Lymphocytic Leukemia
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Breast Cancer
    Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Advanced Malignant Solid Tumors
    A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients
    Pfizer Investigational Site
    Bronx, New York 10461
    Cancer
    Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Lymphoma, Nonneoplastic Condition
    Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Veliparib and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
    Montefiore Medical Center

    Trial Locations
    Montefiore Medical Center
    Montefiore Medical Center-Weiler Division
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
    Montefiore Medical Center
    Bronx, New York 10467-2490
    HIV Infection, Recurrent Anal Cancer, Recurrent Breast Cancer, Recurrent Esophageal Cancer, Recurrent Gastric Cancer, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Anal Cancer, Stage IV Breast Cancer, Stage IV Esophageal Cancer, Stage IV Gastric Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Unspecified Adult Solid Tumor, Protocol Specific
    MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Triple-negative Breast Cancer
    Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Colon Cancer Liver Metastasis
    CP-751,871 Treatment For Patients With Multiple Myeloma
    Pfizer Investigational Site
    Bronx, New York 10461
    Multiple Myeloma
    Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
    Albert Einstein Cancer Center
    Bronx, New York 10461
    Solid Tumors, Advanced Cancer, Cancer, Neoplasms
    Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer
    Eastchester Center for Cancer Care
    Bronx, New York 10469
    Metastatic Pancreatic Adenocarcinoma
    A Study of Tarceva Before Surgery in Non-Small Cell Lung Cancer Patients Who Have EGFR Positive Tumors.
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Non-Small Cell Lung Cancer